Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Myriad Genetics Inc
SWB:MYD
Myriad Genetics Inc
SWB:MYD
Price:
2.726
EUR
14.06%
Market Closed
Market Cap:
€245m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Myriad Genetics Inc
SWB:MYD
|
US |
|
Breville Group Ltd
F:HDE
|
AU |
|
Kraft Heinz Co
NASDAQ:KHC
|
US |
|
Datagate Bilgisayar Malzemeleri Ticaret AS
IST:DGATE.E
|
TR |
|
Henkel AG & Co KGaA
OTC:HENKY
|
DE |
|
SPS Commerce Inc
NASDAQ:SPSC
|
US |
|
U
|
United Rentals Inc
XMUN:UR3
|
US |
|
A
|
Ajinomoto Co Inc
SWB:AJI
|
JP |
|
R
|
Royal Unibrew A/S
SWB:0R1
|
DK |
|
JGC Holdings Corp
TSE:1963
|
JP |
Wall St Price Targets
MYD Price Forecast
Based on 10 analysts
Based on 10 analysts
+7% Upside
from
€2.726
today
Myriad Genetics Inc (MYD)’s 12-month stock price forecast through August 2027 has a consensus target of €2.919, implying 7% upside. The forecast is based on price targets from 10 Wall Street analysts.
MYD Analyst Rating
No ratings yet
No ratings yet
Myriad Genetics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
2.919
EUR
2.919
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 2.919 EUR with a low forecast of 1.806 EUR and a high forecast of 4.694 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
8%
8%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 8%.